Table 1.

Selected headers from the spreadsheet.

Clinical/survival variable	Description
Interval_BL	Number of Days between HCC diagnosis (either by previous imaging or biopsy) and pre-procedural (baseline) CT
Interval_FU	Number of Weeks between follow-up and baseline studies
TTP	Number of weeks between the procedure and the first evidence of tumor progression.
Death_1_StillAlive orLostToFU_0	Binary value (0 or 1), “1” denotes patient died at follow-up date, while “0” denotes patient still alive or lost to follow-up
Age	Patient age at diagnosis (not at baseline CT)
Pathology	Degree of differentiation of HCC according to histopathological assessment
PS_bclc	Performance status as component for BCLC classification
CPG	Child Pugh grading
Tr_Size	Actual pathological tumor size in cm
T_involvment	Liver involvement by the tumor, either less than 50% involvement of liver or more.
AFP	Alpha fetoprotein level (ng/ml)
CLIP_Score	CLIP score
Okuda	Okuda score
TNM	TNM staging
BCLC	Barcelona Clinic Liver Cancer classification
Chemotherapy	Chemotherapy regimen used for TACE procedure, either DEB-TACE or conventional TACE.

Abbreviations: HCC, hepatocellular carcinoma; CT, computed tomography; BCLC, Barcelona Clinic Liver Cancer; AFP, alpha feto-protein; TACE, transarterial chemo-embolization; DEB-TACE, drug-eluting beads TACE.